Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine in Breast Cancer Patients With CNS Progression
NCT01077726Phase 2Completed
- Sponsor
- Roche
- Start
- Jan 2010
- Primary completion
- Dec 2010
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in breast cancer, sponsored by Roche. Started Jan 2010; status: completed.
02
Drugs
capecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01077726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01077726.